Covid-19 Impact on Molecular Diagnostics Market Pegged for Robust Expansion by 2027

Comments · 42 Views

The molecular diagnostics market was estimated at USD 23.6 billion in 2021 and is likely to grow at a CAGR of 4.6% during 2022-2027 to reach USD 30.9 billion by 2027.

According to Stratview Research’s latest report, titled “Molecular Diagnostics Market Size, Share, Trend, Forecast, Competitive Analysis, and Growth Opportunity: 2022-2027”, the Molecular Diagnostics Market is segmented by Product Type (Reagents Kits, Instruments, and Others), by Technique Type (Polymerase Chain Reaction, Isothermal Amplification, Hybridization, Sequencing, Microarray, and Others), by Application Type (Infectious Diseases, Blood Screening, Oncology, Genetic Tests, and Others), by End-User Type (Hospitals, Diagnostic Laboratories, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World). This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the Molecular Diagnostics Market.

Market Insights

According to analysts, the molecular diagnostics market was estimated at USD 23.6 billion in 2021 and is likely to grow at a CAGR of 4.6% during 2022-2027 to reach USD 30.9 billion by 2027.

What is a molecular diagnostic?

Molecular diagnostics is a set of techniques that employ molecular biology to analyze biological markers in the genome and proteome, as well as how cells express their genes as proteins.

Molecular Diagnostics Market COVID Impact

The global pandemic Covid-19 impacted almost every industry and shook the market. However, the pandemic increased the need of developing diagnostic instruments and diagnostic service centers and hence there was a positive impact on the molecular diagnostics market.

Market Dynamics

The molecular diagnostics market is mainly driven by:

  • Increasing incidence of cancer,
  • Growing prevalence of infectious diseases,
  • Increasing occurrence of bacterial and viral diseases,
  • Advancements in molecular diagnostic techniques,
  • Government funding to support RD in molecular diagnostics.

The list of Key Players in the report are -

The market for Molecular Diagnostics is gradually consolidating with major companies that are performing mergers acquisitions to quickly gain the leading position and to tap the growing opportunities in this briskly expanding market. Some of the major key players in the Molecular Diagnostics Market are listed below.

  • Agilent Technologies, Inc.
  • BioMerieux SA
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Novartis AG
  • QIAGEN N.V.
  • Siemens Healthineers AG
  • TBG Diagnostics Limited
  • Thermo Fisher Scientific Inc.

Report Features -

This market report includes the following features –

  • Market structure: Overview, industry life cycle analysis, supply chain analysis.
  • Market environment analysis: Growth drivers and constraints.
  • Market trend and forecast analysis.
  • Competitive landscape and dynamics: Market share, Product portfolio, New Product Launches, MAs etc.
  • Attractive market segments and associated growth opportunities.
  • Emerging trends.

Custom Research:

Stratview research offers custom research services across the sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected]

About Stratview Research –

Stratview Research is a leading market research firm that offers wide range of services like syndicated market reports, consulting, sourcing intelligence, and customer research, etc. Stratview Research’s offerings include comprehensive market intelligence in the form of research reports, and consulting services. Our team which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 500 companies.

 

 

Comments